Login
$INO
$1.39 -$0.01 (0.71%) After hours

$INO SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
10 Nov 2026 8-K: Results of Operations and Financial Condition

INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights

10 Nov 2026 10-Q
09 Nov 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more

Introductory. Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of (i) 58,747,235 shares of its common stock...

06 Nov 2026 424B5
06 Nov 2026 FWP
05 Nov 2026 8-K: Results of Operations and Financial Condition

Inovio Pharmaceuticals, Inc. (the “Company”) is providing the following financial information. As of September 30, 2026, the Company estimates that its cash, cash equivalents and short-term investments were approximately $48.4 million.

05 Nov 2026 424B5
05 Nov 2026 SCHEDULE 13G/A
02 Nov 2026 8-K: Regulation FD Disclosure; Other Events

FDA Accelerated Approval of VOCERYQ™ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) Investor Call November 2, 2026 Exhibit 99.2

06 Oct 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

This Amendment (the “Amendment”) to the Amended and Restated Bylaws (the “Bylaws”) of Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), is made effective as of the date first above written in accordance with Artic...

12 Aug 2026 8-K: Results of Operations and Financial Condition

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

12 Aug 2026 10-Q
12 Aug 2026 SCHEDULE 13G/A
07 Aug 2026 SCHEDULE 13G
06 Aug 2026 SCHEDULE 13G/A
31 Jul 2026 SCHEDULE 13G
31 Jul 2026 8-K: Entry into a Material Definitive Agreement; Other Events

Warrants to Purchase Up to 42,105,264 Shares of Common Stock (or Pre-Funded Warrants in lieu thereof)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support